Active substance
Acepromazine maleate.
Indications
- Tranquiliser for handling nervous animals and/or animals in stressful situations (clinical examinations, diagnostic tests, travel sickness, etc.).
- Premedication prior to anaesthesia, enabling doses of analgesics and general anaesthetic to be reduced and counteracting the emetic effect of opiates.
- Post-operative, facilitates gentle awakening.
Dosage and route of administration
Dogs:
Tranquilisation not followed by anaesthesia: 0.2 – 0.4 ml/10 kg b.w. IM.
Premedication for anaesthesia: 0.02 – 0.1 ml/10 kg b.w. IM.
Post-operative sedation: 0.02 – 0.1 ml/10 kg b.w. IV.
Cats:
Tranquilisation not followed by anaesthesia: 0.02 – 0.04 ml/kg b.w. IM.
Premedication for anaesthesia: 0.01 – 0.02 ml/kg b.w. IM.
Post-operative sedation: 0.002 – 0.01 ml/kg b.w. IV.
When used for pre-anaesthesia purposes or to enhance effect of general anaesthetic, dose of anaesthetic can be reduced by 30-50%.
Horses not intended for human consumption:
Sedation without subsequent anesthesia: (1–2 ml / 100 kg b.w.) by intramuscular route.
Premedication for anesthesia: (0.6–1 ml / 100 kg b.w.) by intramuscular route or alternatively (0.4–0.6 ml / 100 kg b.w.) by intravenous route.
Adjunct treatment in spasmodic colic: (0.4–0.8 ml / 100 kg b.w.) by intramuscular or intravenous route
Use during gestation or lactation
Do not use during last term of gestation.
Presentations
25 and 100 ml vials.
Registry no. 3934 ESP